优化心力衰竭患者心脏性猝死的一级预防
本文综述了心力衰竭患者心脏性猝死一级预防的现状与挑战。既往ICD关键试验以LVEF降低为入选标准,现行指南据此推荐ICD植入,但当代药物治疗已降低LVEF降低患者的SCD风险,而LVEF保留患者SCD风险高却未推荐ICD。文章讨论了SCD风险预测的局限性、正在进行的临床试验对推荐的影响,以及利用人工智能和机器学习构建动态风险预测模型以更好匹配ICD获益的前景。
要点
- 现行ICD一级预防推荐主要基于LVEF,但当代药物治疗已降低LVEF降低患者的SCD风险,推荐不再最优。
- LVEF保留的心衰患者SCD是心血管死亡主因,但ICD未推荐用于该人群的一级预防。
- 需利用诊断测试变量和人工智能/机器学习构建动态风险预测模型,以更准确识别个体SCD风险并匹配ICD获益。
核心结论
- 基于LVEF的ICD一级预防推荐已不再最优,需发展更准确预测个体SCD风险的动态模型以优化患者选择。
研究设计与样本
- 本文为综述,总结了SCD发病率下降趋势、SCD风险与现行指南推荐之间差距扩大的原因,并讨论了风险预测的局限性和正在进行的临床试验的潜在影响。
主要发现
- 当代药物治疗已降低LVEF降低心衰患者的SCD风险,使得该人群中越来越大比例的患者终身无需ICD保护。
- LVEF保留的心衰患者中SCD是心血管死亡的主要原因,但ICD未被推荐用于该人群的一级预防。
- 过去30年患者管理、诊断测试和数据处理进展表明,基于LVEF的ICD一级预防推荐已不再最优。
临床怎么用
- 临床选择ICD一级预防时需认识到仅依据LVEF的局限性,关注正在发展的风险预测模型以更准确识别高SCD风险个体。
局限性
- 当前预测SCD风险的能力存在局限性,需要解决以更好识别个体风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Implantable cardioverter-defibrillators (ICDs) protect patients from sudden cardiac death (SCD). Landmark trials demonstrating their efficacy for primary prevention in patients with heart failure (HF) used reduced left ventricular ejection fraction (LVEF) as a major inclusion criterion and current recommendations for ICD implantation rely on this variable in patient selection. However, contemporary medical management has reduced the risk of SCD in patients with reduced LVEF so that an increasingly large proportion of this population never requires the protection offered by the device. Although SCD is the major cause of cardiovascular mortality in HF patients with preserved LVEF, ICDs are not recommended for primary prevention in this subset of the population. Advances in patient management, diagnostic testing, and data processing over the past 30 years have made it apparent that recommendations for ICD use for primary prevention of SCD are no longer optimal. This review summarizes the declining incidence of SCD and reasons for the widening gap between risk of SCD and current guideline recommendations for use of ICDs in the HF population. It discusses limitations in our ability to predict risk of SCD that need to be addressed and the potential impact of ongoing clinical trials on recommendations for ICD use for primary prevention of SCD. Patient-related variables including those available from diagnostic tests that could be used to generate prediction models that more accurately identify magnitude of risk of SCD in individual patients are identified. The use of artificial intelligence processing of data from diagnostic tests to facilitate and standardize extraction of predictive variables and the use of machine learning algorithms for developing risk prediction models are discussed. The review concludes by describing a dynamic approach for generating novel risk prediction models that could better align risk of SCD with the benefits of ICD implantation in patients with HF and that could evolve over time as additional treatment strategies that alter risk of SCD are introduced in the future.
引用
- Wallace, Wong, Desmarais, et al. Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure. J Am Coll Cardiol. 2025. PMID: 40738564. doi:10.1016/j.jacc.2025.05.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。